TOLGRESS-2 10

About

Tolterodine is an antimuscarinic agent primarily used in the management of overactive bladder (OAB) syndrome, a common condition characterized by symptoms of urinary urgency, frequency, and urge incontinence. It functions by competitively antagonizing muscarinic receptors, particularly M2 and M3 subtypes, which are predominantly found in the bladder detrusor muscle. This pharmacological action leads to the inhibition of involuntary detrusor contractions, thereby increasing the functional bladder capacity and reducing the bothersome symptoms associated with OAB. Its relatively selective action on bladder receptors helps to minimize systemic anticholinergic side effects compared to older agents. Tolterodine is available in both immediate-release and extended-release formulations, with the latter offering the convenience of once-daily dosing, which can significantly improve patient compliance and provide sustained therapeutic effect throughout the day and night. Clinical studies have consistently demonstrated its efficacy in improving OAB symptoms and enhancing the overall quality of life for affected individuals, making it a valuable treatment option.

Uses

• Treatment of overactive bladder with symptoms of urge urinary incontinence.
• Management of urinary urgency.
• Reduction of urinary frequency.
• Alleviation of nocturia associated with OAB.

Directions For Use

Take orally, usually once daily with or without food, as directed by your physician. Swallow the extended-release capsule whole; do not chew or crush.

Benefits

• Reduces episodes of urge incontinence.
• Decreases the frequency of urination.
• Alleviates sudden urges to urinate.
• Improves bladder control and capacity.
• Enhances overall quality of life for OAB patients.
• Offers convenient once-daily dosing for extended-release forms.

Side Effects

• Dry mouth
• Constipation
• Headache
• Dizziness
• Blurred vision
• Dry eyes
• Abdominal pain
• Dyspepsia
• Fatigue
• Somnolence
• Urinary retention
• Nervousness

Safety Measures

• Alcohol - Alcohol may increase the risk of dizziness and drowsiness when taken with this medication. It is advisable to limit or avoid alcohol consumption.
• Pregnancy - Use during pregnancy should only be considered if the potential benefit outweighs the potential risk to the fetus, as human data are limited. Consult a doctor.
• Breastfeeding - It is unknown if tolterodine passes into breast milk. A decision should be made whether to discontinue nursing or the drug, considering the importance of the drug to the mother.
• Liver - Use with caution in patients with hepatic impairment; dosage adjustment may be necessary. Severe liver disease may contraindicate its use.
• Kidney - Use with caution in patients with renal impairment; dosage adjustment may be necessary, especially in severe cases.
• Lung - Generally safe for use in patients with lung conditions, but caution is advised in those with conditions like uncontrolled narrow-angle glaucoma or myasthenia gravis, which can be exacerbated by anticholinergics.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.